This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rothschild, B. L. Articles by Weed, S. A. Search for Related Content PubMed PubMed Citation Articles by Rothschild, B. L. Articles by Weed, S. A.

Cortactin Overexpression Regulates Actin-Related Protein 2/3 Complex Activity, Motility, and Invasion in Carcinomas with Chromosome 11q13 Amplification

Departments of ¹ Craniofacial Biology, ² Radiation Oncology, and ³ Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado; ⁴ Mary Babb Randolph Cancer Center, Department of Neuroscience and Anatomy, West Virginia University, Morgantown, West Virginia; and ⁵ Department of Basic Science and Craniofacial Biology, College of Dentistry, New York University, New York, New York

Requests for reprints: Scott A. Weed, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26508-9300. Phone: 304-293-3016; Fax: 304-293-4667; E-mail: sweed{at}hsc.wvu.edu.

Carcinoma cell motility and invasion are prerequisites for tumor cell metastasis, which requires regulation of the actin cytoskeleton. Cortactin is an actin-related protein 2/3 (Arp2/3) complex–activating and filamentous (F)-actin–binding protein that is implicated in tumor cell motility and metastasis, partially by its ability to become tyrosine phosphorylated. Cortactin is encoded by the CTTN gene and maps to chromosome 11q13, a region amplified in many carcinomas, including head and neck squamous cell carcinoma (HNSCC). CTTN gene amplification is associated with lymph node metastasis and poor patient outcome, and cortactin overexpression enhances motility in tumor cells lacking 11q13 amplification. However, a direct link between increased motility and invasion has not been reported in tumor cells with chromosome 11q13 amplification and cortactin overexpression. In this study, we have examined the relationship between CTTN amplification and tumor cell motility in HNSCC. In 11 of 39 (28%) HNSCC cases, cortactin overexpression determined by immunohistochemistry correlates with lymph node metastasis and CTTN gene amplification. HNSCC cells containing cortactin gene amplification and protein overexpression display increased binding and activation of Arp2/3 complex, and were more motile and invasive than HNSCC cells lacking CTTN amplification. Down-regulation of cortactin expression in CTTN-amplified HNSCC cells by small interfering RNA impairs HNSCC motility and invasion. Treatment of HNSCC cells with the epidermal growth factor receptor inhibitor gefitinib inhibits HNSCC motility and down-regulates cortactin tyrosine phosphorylation. These data suggest that cortactin may be a valid prognostic and therapeutic marker for invasive and metastatic HNSCC and other carcinomas with 11q13 amplification. (Cancer Res 2006; 66(16): 8017-25)

This article has been cited by other articles:

				J. Han, W. Hou, L. A. Goldstein, C. Lu, D. B. Stolz, X.-M. Yin, and H. Rabinowich Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells J. Biol. Chem., July 11, 2008; 283(28): 19665 - 19677. [Abstract] [Full Text] [PDF]

				L. Jia, T. Uekita, and R. Sakai Hyperphosphorylated Cortactin in Cancer Cells Plays an Inhibitory Role in Cell Motility Mol. Cancer Res., April 1, 2008; 6(4): 654 - 662. [Abstract] [Full Text] [PDF]

				P. Timpson, A. S. Wilson, G. M. Lehrbach, R. L. Sutherland, E. A. Musgrove, and R. J. Daly Aberrant Expression of Cortactin in Head and Neck Squamous Cell Carcinoma Cells Is Associated with Enhanced Cell Proliferation and Resistance to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Cancer Res., October 1, 2007; 67(19): 9304 - 9314. [Abstract] [Full Text] [PDF]

				W.-C. Tsai, J.-S. Jin, W.-K. Chang, D.-C. Chan, M.-K. Yeh, S.-C. Cherng, L.-F. Lin, L.-F. Sheu, and Y.-C. Chao Association of Cortactin and Fascin-1 Expression in Gastric Adenocarcinoma: Correlation With Clinicopathological Parameters J. Histochem. Cytochem., September 1, 2007; 55(9): 955 - 962. [Abstract] [Full Text] [PDF]

				E. S. Clark, A. S. Whigham, W. G. Yarbrough, and A. M. Weaver Cortactin Is an Essential Regulator of Matrix Metalloproteinase Secretion and Extracellular Matrix Degradation in Invadopodia Cancer Res., May 1, 2007; 67(9): 4227 - 4235. [Abstract] [Full Text] [PDF]

				M.-L. Luo, X.-M. Shen, Y. Zhang, F. Wei, X. Xu, Y. Cai, X. Zhang, Y.-T. Sun, Q.-M. Zhan, M. Wu, et al. Amplification and Overexpression of CTTN (EMS1) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance Cancer Res., December 15, 2006; 66(24): 11690 - 11699. [Abstract] [Full Text] [PDF]